4DMedical, a pioneer in software-based respiratory imaging, has successfully secured over $100 million in new institutional funding. This significant investment is earmarked to accelerate the adoption of its innovative CT:VQ™ technology across the United States and further enhance its research and development efforts, solidifying its leadership in software-based lung imaging.
Key Takeaways
- Significant Funding Boost: Over $100 million raised to fuel U.S. expansion and R&D.
- CT:VQ™ Expansion: Focus on scaling hospital deployments of the FDA-cleared CT:VQ™ product.
- Early Adopter Success: Technology already deployed at leading institutions like Stanford and Cleveland Clinic.
- Technological Advancement: Investment to bolster R&D and maintain a competitive edge in functional lung imaging.
Accelerating U.S. Adoption
The newly acquired capital will be instrumental in expanding the U.S. presence of 4DMedical’s flagship "CT:VQ™" product. This FDA-cleared Software-as-a-Service (SaaS) technology provides crucial ventilation and perfusion insights derived from CT scans. Within just four months of receiving FDA clearance, CT:VQ™ was adopted by four prominent U.S. academic medical centers: Stanford, Cleveland Clinic, University of Miami, and UC San Diego Health. This rapid uptake highlights the growing demand from clinicians for quantified, actionable, and functional information that traditional imaging methods cannot provide, yet is vital for diagnosis, treatment planning, and patient monitoring.
Driving Innovation and Market Dominance
Andreas Fouras, PhD, Founder and CEO of 4DMedical, expressed enthusiasm about the funding, stating, "This is an extraordinarily important and validating event for multiple reasons." He emphasized that the investment reflects the global recognition of 4DMedical’s technological leadership, particularly with groundbreaking products like CT:VQ™, and acknowledges the company’s commercial progress and substantial growth potential in the U.S. market. With this enhanced financial backing, 4DMedical aims to scale adoption, accelerate R&D, deepen partnerships, and ultimately dominate the global market for software-based lung imaging tools.
What the Funding Enables for Healthcare Providers
The funding will be strategically allocated to support health systems in implementing CT:VQ™ at scale. Key areas of focus include:
- Commercial Expansion: Broadening the reach of CT:VQ™ across U.S. academic medical centers and health systems, emphasizing real-world application and multidisciplinary use.
- Customer Support: Enhancing customer success, training, and technical support to ensure seamless integration into existing clinical workflows and consistent utilization.
- Research and Development: Continuing to invest in R&D to expand 4DMedical’s technological leadership, product portfolio, and capabilities in functional lung imaging.
- Operational Scaling: Increasing operational capacity and flexibility to capitalize on future growth opportunities and sustain clinical partnerships.
Following this capital raise, 4DMedical reports a pro forma cash position exceeding $130 million, providing a strong foundation for its U.S. expansion strategy and supporting its growing installed base.
Seamless Integration and Future Outlook
4DMedical’s solutions are designed as SaaS offerings, ensuring easy integration with existing hospital IT infrastructure. The company also highlighted strategic collaborations, including one with Philips, aimed at facilitating broader adoption pathways. Hospitals and imaging networks interested in evaluating CT:VQ™ are encouraged to contact 4DMedical for implementation details and demonstrations.
Sources
- 4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in
Software-Based Lung Imaging, Laotian Times.
Founder Dinis Guarda
IntelligentHQ Your New Business Network.
IntelligentHQ is a Business network and an expert source for finance, capital markets and intelligence for thousands of global business professionals, startups, and companies.
We exist at the point of intersection between technology, social media, finance and innovation.
IntelligentHQ leverages innovation and scale of social digital technology, analytics, news, and distribution to create an unparalleled, full digital medium and social business networks spectrum.
IntelligentHQ is working hard, to become a trusted, and indispensable source of business news and analytics, within financial services and its associated supply chains and ecosystems
